Bougard Nicolas, Piette Vincent, Schleich Florence, Louis Renaud
Service de Pneumologie, CHU Liège, Belgique.
Service des Soins intensifs, CHR Huy, Belgique.
Rev Med Liege. 2024 Jun;79(5-6):405-410.
Allergen immunotherapy is still the only curative treatment for respiratory allergies. It is based on repeated administration of allergenic extracts to sensitized patients. It can be administered either by subcutaneous or by sublingual route. The purpose of the treatment is to modulate the immune response to a specific allergen and to alter the course of the disease over a long-term period. Numerous studies and meta-analyses have demonstrated its efficacy in terms of symptoms and quality of life improvement as well as reduction of the allergic march. Indication of allergen immunotherapy includes moderate to severe allergic rhinitis and mild to moderate allergic asthma from GINA step 3. Early intervention in sensitized patients is nowadays promoted.
变应原免疫疗法仍然是呼吸道过敏的唯一治愈性治疗方法。它基于向致敏患者反复给予变应原提取物。可通过皮下或舌下途径给药。该治疗的目的是调节对特定变应原的免疫反应,并长期改变疾病进程。大量研究和荟萃分析已证明其在改善症状和生活质量以及减少过敏进程方面的疗效。变应原免疫疗法的适应症包括中度至重度过敏性鼻炎以及GINA第3步的轻度至中度过敏性哮喘。如今提倡对致敏患者进行早期干预。